STOCK TITAN

Scinai Immunotherapeutics Ltd. SEC Filings

SCNI NASDAQ

Welcome to our dedicated page for Scinai Immunotherapeutics Ltd. SEC filings (Ticker: SCNI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

NanoAb pipelines, multi-country trials, and a revenue-generating CDMO make Scinai Immunotherapeutics’ SEC disclosures anything but straightforward. If you have ever opened the company’s 10-K hoping to find a simple answer on cash runway or trial timelines, you know the challenge.

Our platform resolves that pain. Stock Titan’s AI breaks down every line item—whether buried in a Scinai Immunotherapeutics annual report 10-K simplified section or tucked into a footnote of the latest Scinai Immunotherapeutics quarterly earnings report 10-Q filing. Instantly surface R&D spend, GMP facility capacity, or pipeline milestones without wading through clinical jargon.

Need real-time transparency? We stream Scinai Immunotherapeutics Form 4 insider transactions real-time, alerting you the moment executives buy or sell shares. Our coverage spans all disclosures, including:

  • Form 4 – track Scinai Immunotherapeutics executive stock transactions Form 4 and gauge insider confidence.
  • 10-Q & 10-K – detailed Scinai Immunotherapeutics earnings report filing analysis with AI-generated plain-English summaries.
  • 8-K – see Scinai Immunotherapeutics 8-K material events explained when trial results or CDMO contracts move the stock.
  • Proxy (DEF 14A) – explore Scinai Immunotherapeutics proxy statement executive compensation to understand incentives.

Each document is paired with "understanding Scinai Immunotherapeutics SEC documents with AI" notes that clarify clinical data, cash burn projections, and CDMO backlog. Search engines and users alike find answers to, "Scinai Immunotherapeutics insider trading Form 4 transactions" or "Scinai Immunotherapeutics SEC filings explained simply" right here—updated the second EDGAR publishes.

Skip the 300-page PDFs. Rely on concise insights, real-time alerts, and AI context so you can focus on decisions, not decoding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
current report

FAQ

What is the current stock price of Scinai Immunotherapeutics Ltd. (SCNI)?

The current stock price of Scinai Immunotherapeutics Ltd. (SCNI) is $1.54 as of September 2, 2025.

What is the market cap of Scinai Immunotherapeutics Ltd. (SCNI)?

The market cap of Scinai Immunotherapeutics Ltd. (SCNI) is approximately 1.5M.
Scinai Immunotherapeutics Ltd.

NASDAQ:SCNI

SCNI Rankings

SCNI Stock Data

1.53M
844.52k
18.22%
28.97%
27.54%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
JERUSALEM